BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26

• FDA

  Syneron Medical Ltd. Candela Announces FDA Clearance Of PicoWay Picosecond Laser For Tattoo Removal

  November 3, 2014

   · 

  6 min read
• Deals

  Mesa Labs Acquires Its UK And Irish Republic Distributor Of Biological Indicators

  November 3, 2014

   · 

  4 min read
• Pharm Country

  Boehringer Ingelheim Corporation Release: FDA Study Of Medicare Patients Reaffirms Safety And Efficacy Profile Of Pradaxa® (Dabigatran Etexilate Mesylate) For NVAF

  November 3, 2014

   · 

  11 min read
• Drug Development

  VBL Therapeutics To Present Interim Phase 2 Data From VB-111 In Recurrent Glioblastoma At 19th Annual Scientific Meeting Of The Society For Neuro-Oncology (SNO)

  November 3, 2014

   · 

  4 min read
• Business

  Hemispherx Biopharma And United States Army Medical Research Institute Of Infectious Diseases (USAMRIID) Collaborate On Alferon® And Ampligen® Against The Ebola Virus

  November 3, 2014

   · 

  5 min read
• Oramed Pharmaceuticals Inc. To Report Key Top Line Results From U.S. Phase 2a Trial With Oral Insulin In Type 1 Diabetes

  November 3, 2014

   · 

  4 min read
• Drug Development

  Anavex Life Sciences Corp. Receives Regulatory Approval To Initiate Phase 2a Clinical Trial Of ANAVEX 2-73 And ANAVEX PLUS For Alzheimer’s Disease

  November 3, 2014

   · 

  4 min read
• Deals

  Actavis And Durata Therapeutics, Inc. Receive U.S. FTC Clearance For Actavis’ Proposed Acquisition Of Durata

  November 3, 2014

   · 

  8 min read
• Biotech Beach

  AtheroNova Inc. Announces Closing Of Public Offering Of Common Stock And Warrants

  November 3, 2014

   · 

  4 min read
• EastGate Acquisitions Corporation Announces Poster Presentation Of The Company’s Proprietary Intraoral Lorazepam Spray At The American Association of Pharmaceutical Scientists Conference

  November 3, 2014

   · 

  5 min read